None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients aged 50 years or older with acute stroke Patients who underwent brain MRI or CT within 1 week of stroke onset Patients who are able to undergo handgrip strength testing and body composition assessment using InBody S10 bioelectrical impedance analysis (BIA) within 1 month after stroke onset Patients who are available for follow-up evaluations at 1, 3, and 12 months after stroke onset through outpatient visits or telephone interviews Patients who provide written informed consent to participate in the study
Exclusion criteria
Exclusion criteria: Patients with severe pre-stroke disability (modified Rankin Scale > 2) Patients with conditions that may independently affect sarcopenia, including end-stage cancer, dialysis-dependent chronic kidney disease, or neuromuscular disorders Patients with contraindications to bioelectrical impedance analysis (BIA), such as pacemakers or implantable cardioverter-defibrillators Patients with anatomical abnormalities of the temporalis muscle or a history of temporalis muscle surgery Patients with poor-quality MRI or CT images that preclude accurate measurement of temporalis muscle thickness Pregnant women or women for whom pregnancy cannot be excluded
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Presence of post-stroke sarcopenia at 1 month after stroke onset | — |
Secondary
| Measure | Time frame |
|---|---|
| Hospital readmission;Mortality;Functional disability assessed by the Modified Rankin Scale (mRS) | — |
Countries
Korea, Republic of
Contacts
KyungHee University Medical Center